This is the case of ladostigil, an inhibitor of acetylcholine esterase (AChE) and the brain monoamine oxidases (MAO) A and B, which has shown efficacy in models of Alzheimer’s disease. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.